• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 10673
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Obstruction/Occlusion (2422)
Event Date 06/12/2020
Event Type  Death  
Manufacturer Narrative
Age at time of event: 18 years or older.Device is a combination product.
 
Event Description
It was reported that a death occurred.The 80% stenosed target lesion was located in the moderately tortuous and mildly calcified left anterior descending coronary artery.A 20 x 2.75mm promus elite drug-eluding stent was implanted with no issues reported.The patient expired post procedure but the physician considered the death as unlikely related to the device.
 
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported, that a death occurred.The 80% stenosed target lesion was located in the moderately tortuous, and mildly calcified left anterior descending coronary artery.A 20 x 2.75mm promus elite drug-eluding stent was implanted with no issues reported.The patient expired post procedure, but the physician considered, the death as unlikely related to the device.It was further reported, that the patient presented to the emergency room with severe angina with shock.And pulmonary edema with symptoms lasting approximately six hours.She was diagnosed with an anterior wall myocardial infarction and thrombolysed elsewhere unsuccessfully.She was taken to the cath lab for percutaneously coronary intervention, where she underwent angioplasty in the proximal left anterior descending coronary artery.Slow flow was obtained.The patient's hemodynamics failed to improve.And she died two days later, due to refractory shock, pulmonary edema and renal shutdown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELITE
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key10253449
MDR Text Key198195336
Report Number2134265-2020-09138
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 08/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/09/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/25/2021
Device Model Number10673
Device Catalogue Number10673
Device Lot Number0024858206
Was Device Available for Evaluation? No
Date Manufacturer Received07/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age60 YR
-
-